SRIPLAW, Our passion, your protection

Your Passion, Our Protection

More than legal protection, we’re true partners to those shaping culture through creativity.

Archives

AHPA Food Allergen Labeling Teleseminar 12/2 at noon EST

The AHPA is sponsoring what looks like a great seminar on the new food allergen labeling requirements we previously discussed on Nutrisuplaw here. It looks like a great lineup.
Read More
READ MORE

New York Times: U.S.O.C. Hires a Maker of Nutritional Supplements and Requires Testing

Well, they say that if it appears in the NY Times, it has officially "arrived." And so it appears that nutritional supplement use by athletes has, on this day in history, found its place in the pages of the paper of record.
Read More
READ MORE

FTC and FDA Both Warn Marketers of Hormone Replacement Supplements

Are government regulators surfing the internet in their spare time looking for supplement makers and marketers violating federal advertising and labeling laws? The answer is yes.
Read More
READ MORE

FDA Denies Lycopene Supplement Health Claims

The FDA has denied a petition by supplement maker American Longevity for approval of qualified health claims concerning cancer fighting properties of lycopene, an antioxydant found in red fruits like tomatoes and watermelon.
Read More
READ MORE

Federal Appeals Court Orders Supplement Maker to Pay Restitution under FDCA

In a case of first impression under the Federal Food, Drug and Cosmetic Act (FDCA), the Third Circuit Court of Appeals in Philadelphia has held that restitution is available as a remedy and may be ordered against companies that violate the Act.
Read More
READ MORE

What Is Organic? Powerful Players Want a Say

Excellent article in the NY Times on the entry of large food companies into the organic foods business. The article mentions the First Circuit's decision in Harvey v.
Read More
READ MORE

Annual Bibliography of Significant Advances in Dietary Supplement Research

The Office of Dietary Supplements (ODS) at the NIH has released the Annual Bibliography of Significant Advances in Dietary Supplement Research. The press release summarizes this resource: This sixth issue of the Bibliography includes abstracts of the 25 most noteworthy dietary supplement research papers published in 2004, as judged by an international team of reviewers.
Read More
READ MORE

NY Times: USDA about-face on Organic Products

We previously reported here about the USDA's decision to back down from its ill conceived policy to refuse organic certification to non-food products. It appears that the NY Times has caught up to our news cycle here at nutrisuplaw.com
Read More
READ MORE

Drug’s Active Ingredient Sold on Internet

This article titled Big problem for BioStratum describes how the active ingredient in this company's drug (now in Phase II trials) is available for purchase on the Internet as a nutritional supplement.
Read More
READ MORE

FTC Injunction against “Fountain of Youth” Oral Sprays

The FTC reports it has obtained a preliminary injunction against several nutritional supplement companies and marketers of oral sprays that supposedly contain human growth hormone (HGH) to stop them from making alleged false and deceptive claims and from sending illegal spam.
Read More
READ MORE

Brazilian Diet Pills Causing Stir

A segment on the Today Show this morning saw Katy Couric questioning two women about the new Brazilian diet pills they had been taking. Apparently, the women tested positive for amphetamines on a pre-employment drug test.
Read More
READ MORE

AHPA nudges nutritional supplement-makers on allergen law labeling

Effective Jan. 1, 2006, all food companies, including dietary and nutritional supplement manufacturers, must include warnings if they contain "major allergens." For article, click here. The new requirements are part of the 2004 Food Allergen Labeling and Consumer Protection Act.
Read More
READ MORE

The Tort Wars, at a Turning Point

This article from Sunday's New York Times is a must read for attorneys involved in defending ephedra supplement manufacturers and other dietary supplement lawsuits. The article describes how defense lawyers were able to take apart the class action against silica manufacturers through ingenuity and downright good lawyering.
Read More
READ MORE

Dietary Supplement Marketing Company Files Suit Against Federal Trade Commission

A battle is raging between supplement marketer ITV Direct, Inc. and the FTC. The FTC previously sued ITV for FTC act violations. FTC v. ITV here.
Read More
READ MORE

Sen. Durbin Introduces, Withdraws AER Amendment

This from the 10/10/05 edition of the NNFA Supplement email newsletter: In an effort to draw attention to adverse event reporting (AER) for dietary supplements, Sen.
Read More
READ MORE

Role Urged for Albany in Policing Dietary Aids

An article in yesterday's New York Times discusses the release of a state task force report recommending that NY take a role in overseeing the dietary supplement industry.
Read More
READ MORE

Class action sought for ‘Dr. Phil’ diet suit

CNN article here. The FTC has previously investigated the company who made Dr. Phil's supplements, CSA Neutraceuticals, LP, but closed the investigation after the company agreed to stop making certain claims.
Read More
READ MORE

Feds search the home of the “father of prohormones.”

"Federal agents raided the laboratory and home of Patrick Arnold, a Champaign chemist who authorities believe created one of the steroids at the heart of the BALCO sports doping scandal, the San Francisco Chronicle reported Friday.
Read More
READ MORE

Dietary Supplement/Food Labeling Electronic Newsletter

This just in from the FDA: September 2005 (#10) IN THIS ISSUE: 1. FDA's Letter to Food Manufacturers on "and/or" Ingredient Labeling of Nutritive Sweeteners in Soft Drink Products.
Read More
READ MORE

Government Settles Cortislim case

For the article, click here. The FTC case file is here. Update: Utah Daily Chronicle, "Former nutrition professor pays for not supporting claims."
Read More
READ MORE
1 12 13 14 15

Get in Touch or Submit Your Case for Review

From general questions to potential IP misuse, choose the option that best fits your case.

Our team will review your submission and get back to you as soon as possible.